The Precision Peptide Company Inc. (CSE:BPC)

CSE:BPC Revenue

The Precision Peptide Company had revenue of 42.99K CAD in the quarter ending January 31, 2026. This brings the company's revenue in the last twelve months to 92.71K, up 2,116.42% year-over-year. In the fiscal year ending October 31, 2025, The Precision Peptide Company had annual revenue of 49.72K with 307.47% growth.

• Revenue (ttm): 92.71K
• Revenue Growth: +2,116.42%
• P/S Ratio: 228.57
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 21.19M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Oct 31, 2025	49.72K	37.52K	307.47%
Oct 31, 2024	12.20K	-273.39K	-95.73%
Oct 31, 2023	285.59K	-295.40K	-50.84%
Oct 31, 2022	580.99K	463.57K	394.79%
Oct 31, 2021	117.42K	-	-

Data Source: S&P Global Market Intelligence Last updated: Jan 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 19, 2026

Data Sources Report a data error